IMMUNOSUPPRESSIVE ACTIVITY OF SERA OF PREGNANT-WOMEN AN CYTOTOXIC T-LYMPHOCYTE-MEDIATED CYTOLYSIS .1. CHARACTERIZATION OF THE ACTIVE FRACTION

被引:4
作者
LETELLIER, C [1 ]
FIZET, D [1 ]
BALTZ, T [1 ]
VEZON, G [1 ]
机构
[1] UNIV BORDEAUX 2,IMMUNOL & BIOL MOLEC PARASITES LAB,BORDEAUX,FRANCE
关键词
IMMUNOLOGY; HUMAN PREGNANCY; IMMUNOSUPPRESSIVE ACTIVITY; CYTOTOXIC T LYMPHOCYTES; CELL-MEDIATED LYMPHOLYSIS ASSAY;
D O I
10.1159/000292509
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
Sera of healthy pregnant women have a nonspecific inhibitory activity on the specific cytolytic activity of activated cytotoxic T lymphocytes in vitro. The serum fraction of pregnant females which is responsible for this activity has been characterized. The equivalent fraction derived from sera of healthy men has a similar but reduced activity compared with the female fraction. This suppressive factor seems to be activated during pregnancy. Moreover, this study sheds some light an the reasons behind the attenuation of the maternal immune system during pregnancy.
引用
收藏
页码:1 / 5
页数:5
相关论文
共 23 条
[1]   GLYCOPROTEIN GLYCOSYLATION AND THE IMMUNOSUPPRESSIVE EFFECTS OF HUMAN-PREGNANCY SERUM [J].
ARKWRIGHT, P ;
RADEMACHER, T ;
MARSHALL, J ;
DWEK, R ;
REDMAN, C .
JOURNAL OF REPRODUCTIVE IMMUNOLOGY, 1992, 21 (01) :97-102
[2]   PLACENTAL IMMUNOREGULATORY FACTORS [J].
CHAOUAT, G .
JOURNAL OF REPRODUCTIVE IMMUNOLOGY, 1987, 10 (03) :179-188
[3]   HORMONE-INDUCED PREIMPLANTATION LYT-2+ MURINE UTERINE SUPPRESSOR CELLS PERSIST AFTER IMPLANTATION AND MAY REDUCE THE SPONTANEOUS-ABORTION RATE IN CBA/J MICE [J].
CLARK, DA ;
BRIERLEY, J ;
BANWATT, D ;
CHAOUAT, G .
CELLULAR IMMUNOLOGY, 1989, 123 (02) :334-343
[4]  
CLARK DA, 1991, COLLOQ INSE, V212, P171
[5]  
DAVIES M, 1985, AM J REPROD IM MIC, V9, P84
[6]  
DAVIES M, 1985, AM J REPROD IM MIC, V9, P77
[7]  
DEBRE P, 1988, CLONAGE LYMPHOCYTES, P19
[8]   CHARACTERIZATION OF P4, A NATURAL INHIBITOR OF CELLULAR CYTO-TOXICITY REACTION IN PREGNANT-WOMEN [J].
FIZET, D ;
BOUSQUET, J .
GYNECOLOGIC AND OBSTETRIC INVESTIGATION, 1985, 20 (04) :179-185
[9]  
FIZET D, 1983, CLIN EXP IMMUNOL, V52, P648
[10]  
GREGORY CD, 1985, CLIN EXP IMMUNOL, V62, P121